Pharmacy Benefit Manager Transparency, drug copay price caps.
2026 · 3rd Quarter (July 1 - Sep 30)
ALLERGY & ASTHMA NETWORK
Filed by ALLERGY & ASTHMA NETWORK.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Sep 30, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- ALLERGY & ASTHMA NETWORK
- Client
- ALLERGY & ASTHMA NETWORK
- Filing UUID
- 5d00a5aa-b6db-4cf9-b662-6237b6189d7b
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Endangerment Finding Repeal, Clean Air Standards, Data center standards
School nurse staffing
Medicaid funding cuts
ADINA Act, Food Allergen Labeling
Food Allergen Labeling, Epinephrine Access in Community Settings
Regulatory agency program funding - Centers for Disease Control and Prevention National Asthma Control Program.
Health insurance affordability, copay assistance, step therapy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.